ANNA WEIR: Open Payments
NPI 1952765810 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 15 payments from 10 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $205 |
| GENZYME CORPORATION | 2 | $57 |
| Almirall LLC | 2 | $45 |
| Galderma Laboratories, L.P. | 1 | $36 |
| Lilly USA, LLC | 1 | $28 |
| Incyte Corporation | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: RINVOQ, DUPIXENT, EBGLYSS, SKYRIZI, OPZELURA, Klisyri, COSENTYX, Seysara.
Industry payments across FL — which companies pay providers there.
